During the corresponding time, Biofrontera Inc recorded a revenue increase by 32.92 % year on year, sequentially revenue grew by 21.67 %. While revenue at the Biofrontera Inc 's corporate clients
Biofrontera Inc's Comment on Sales, Marketing and Customers
As of December 31, 2025, the company serves a diverse customer base, with no single customer accounting for more than 10% of net revenues or net accounts receivable. The company primarily operates in the United States market, focusing on dermatology through products such as Ameluz and pursuing additional approvals and label extensions. It seeks to strengthen relationships within the dermatology community. The company also notes potential customer consolidations into Group Purchasing Organizations (GPOs) aimed at reducing costs.
Biofrontera Inc’s Comment on Sales, Marketing and Customers
As of December 31, 2025, the company serves a diverse customer base, with no single customer accounting for more than 10% of net revenues or net accounts receivable. The company primarily operates in the United States market, focusing on dermatology through products such as Ameluz and pursuing additional approvals and label extensions. It seeks to strengthen relationships within the dermatology community. The company also notes potential customer consolidations into Group Purchasing Organizations (GPOs) aimed at reducing costs.
Sources:
Biofrontera Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Biofrontera Inc’s corporate clients.
For your research, we’ve provided 9 tables on Biofrontera Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
